Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- Author
- CAMPOCHIARO, Peter A1 ; BROWN, David M2 ; REICHEL, Elias11 ; SOUBRANE, Gisele12 ; KAPIK, Barry13 ; BILLMAN, Kathleen13 ; KANE, Frances E13 ; GREEN, Kenneth13 ; PEARSON, Andrew3 ; CHEN, Sanford4 ; BOYER, David5 ; RUIZ-MORENO, Jose6 ; GARRETSON, Bruce7 ; GUPTA, Amod8 ; HARIPRASAD, Seenu M9 ; BAILEY, Clare10
[1] Wilmer Eye Institute, Baltimore, Maryland, United States
[2] Vitreoretinal Consultants, Houston, Texas, United States
[3] Department of Ophthalmology and Visual Sciences, University of Kentucky, Lexington, Kentucky, United States
[4] Orange County Retina Medical Group, Santa Ana, California, United States
[5] Retina Vitreous Associates Medical Group, Beverly Hills, California, United States
[6] Institut Oflalmologico Alicante, Spain
[7] Royal Oak Associates, Royal Oak, Michigan, United States
[8] Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
[9] Department of Ophthalmlogy, University of Chicago, Chicago, Illinois, United States
[10] Bristol Eye Hospital, Bristol, United Kingdom
[11] Tufts Medical Center Hospital, Boston, Massachusetts, United States
[12] Intercommunal Hospital of Creteil, Creteil, France
[13] Alimera Sciences, Atlanta, Georgia
FAME Study Group - Source
Ophthalmology (Rochester, MN). 2012, Vol 119, Num 10, pp 2125-2132, 8 p ; ref : 4 ref
- CODEN
- OPHTDG
- ISSN
- 0161-6420
- Scientific domain
- Ophthalmology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Accouchement Acétonide de fluocinolone Corps vitré Diabète Homme Oedème de la rétine Ophtalmologie Corticostéroïde Endocrinopathie Hormone stéroïde Hormone surrénalienne Pathologie de l'oeil Rétinopathie
- Keyword (en)
- Delivery Fluocinolone acetonide Vitreous body Diabetes mellitus Human Retinal edema Ophthalmology Corticosteroid Endocrinopathy Steroid hormone Adrenal hormone Eye disease Retinopathy
- Keyword (es)
- Parto Acetónido de fluocinolona Cuerpo vítreo Diabetes Hombre Edema de la retina Oftalmología Corticoesteroide Endocrinopatía Hormona esteroide Hormona suprarrenal Ojo patología Retinopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B09 Ophthalmology / 002B09I Retinopathies
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B09 Ophthalmology / 002B09N Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20G Delivery. Postpartum. Lactation
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Endocrinopathies Gynecology. Andrology. Obstetrics Ophthalmology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26818699
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ophtha.2012.04.030 
https://dx.doi.org/10.1016/j.ophtha.2012.04.030
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2012.04.030\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2125\";s:8:\"\u0000*\u0000epage\";s:4:\"2132\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"CAMPOCHIARO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:14:\"BROWN, David M\";i:1;s:14:\"REICHEL, Elias\";i:2;s:16:\"SOUBRANE, Gisele\";i:3;s:12:\"KAPIK, Barry\";i:4;s:17:\"BILLMAN, Kathleen\";i:5;s:15:\"KANE, Frances E\";i:6;s:14:\"GREEN, Kenneth\";i:7;s:15:\"PEARSON, Andrew\";i:8;s:13:\"CHEN, Sanford\";i:9;s:12:\"BOYER, David\";i:10;s:17:\"RUIZ-MORENO, Jose\";i:11;s:16:\"GARRETSON, Bruce\";i:12;s:11:\"GUPTA, Amod\";i:13;s:19:\"HARIPRASAD, Seenu M\";i:14;s:13:\"BAILEY, Clare\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2012.04.030\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2125\";s:8:\"\u0000*\u0000epage\";s:4:\"2132\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"CAMPOCHIARO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:14:\"BROWN, David M\";i:1;s:14:\"REICHEL, Elias\";i:2;s:16:\"SOUBRANE, Gisele\";i:3;s:12:\"KAPIK, Barry\";i:4;s:17:\"BILLMAN, Kathleen\";i:5;s:15:\"KANE, Frances E\";i:6;s:14:\"GREEN, Kenneth\";i:7;s:15:\"PEARSON, Andrew\";i:8;s:13:\"CHEN, Sanford\";i:9;s:12:\"BOYER, David\";i:10;s:17:\"RUIZ-MORENO, Jose\";i:11;s:16:\"GARRETSON, Bruce\";i:12;s:11:\"GUPTA, Amod\";i:13;s:19:\"HARIPRASAD, Seenu M\";i:14;s:13:\"BAILEY, Clare\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2012.04.030\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2012.04.030\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2125\";s:8:\"\u0000*\u0000epage\";s:4:\"2132\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"CAMPOCHIARO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:14:\"BROWN, David M\";i:1;s:14:\"REICHEL, Elias\";i:2;s:16:\"SOUBRANE, Gisele\";i:3;s:12:\"KAPIK, Barry\";i:4;s:17:\"BILLMAN, Kathleen\";i:5;s:15:\"KANE, Frances E\";i:6;s:14:\"GREEN, Kenneth\";i:7;s:15:\"PEARSON, Andrew\";i:8;s:13:\"CHEN, Sanford\";i:9;s:12:\"BOYER, David\";i:10;s:17:\"RUIZ-MORENO, Jose\";i:11;s:16:\"GARRETSON, Bruce\";i:12;s:11:\"GUPTA, Amod\";i:13;s:19:\"HARIPRASAD, Seenu M\";i:14;s:13:\"BAILEY, Clare\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2012.04.030\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2125\";s:8:\"\u0000*\u0000epage\";s:4:\"2132\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"CAMPOCHIARO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:14:\"BROWN, David M\";i:1;s:14:\"REICHEL, Elias\";i:2;s:16:\"SOUBRANE, Gisele\";i:3;s:12:\"KAPIK, Barry\";i:4;s:17:\"BILLMAN, Kathleen\";i:5;s:15:\"KANE, Frances E\";i:6;s:14:\"GREEN, Kenneth\";i:7;s:15:\"PEARSON, Andrew\";i:8;s:13:\"CHEN, Sanford\";i:9;s:12:\"BOYER, David\";i:10;s:17:\"RUIZ-MORENO, Jose\";i:11;s:16:\"GARRETSON, Bruce\";i:12;s:11:\"GUPTA, Amod\";i:13;s:19:\"HARIPRASAD, Seenu M\";i:14;s:13:\"BAILEY, Clare\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2012.04.030\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2125\";s:8:\"\u0000*\u0000epage\";s:4:\"2132\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"CAMPOCHIARO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:14:\"BROWN, David M\";i:1;s:14:\"REICHEL, Elias\";i:2;s:16:\"SOUBRANE, Gisele\";i:3;s:12:\"KAPIK, Barry\";i:4;s:17:\"BILLMAN, Kathleen\";i:5;s:15:\"KANE, Frances E\";i:6;s:14:\"GREEN, Kenneth\";i:7;s:15:\"PEARSON, Andrew\";i:8;s:13:\"CHEN, Sanford\";i:9;s:12:\"BOYER, David\";i:10;s:17:\"RUIZ-MORENO, Jose\";i:11;s:16:\"GARRETSON, Bruce\";i:12;s:11:\"GUPTA, Amod\";i:13;s:19:\"HARIPRASAD, Seenu M\";i:14;s:13:\"BAILEY, Clare\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
